Race Oncology Files Three New Patent Applications After Scientific Discoveries, Shares Jump 24%

MT Newswires Live

Sep 16

Race Oncology (ASX:RAC) filed a new composition of matter patent application as well as two additional patent applications covering the optimal manufacturing, formulation, and uses of (E,E)-bisantrene isomer after scientific discoveries into the nature of bisantrene, according to a Tuesday Australian bourse filing.

The firm discovered that each isomer of bisantrene has differing biological properties and anticancer activity. The bisantrene isomers are generated during chemical synthesis or by exposure to visible light and heat. Only the (E,E)-bisantrene isomer has significant anticancer activity.

The patent applications were filed on Sept. 12. They requested accelerated examination of the new applications to aid pharmaceutical partnering discussions.

Its shares jumped 24% in recent trading on Tuesday, reaching the highest point in over two years.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2567217502"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2567217502\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2567217502?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-16 13:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2567217502","market":"sh","top_or_hot":-1,"title":"Race Oncology Files Three New Patent Applications After Scientific Discoveries, Shares Jump 24%","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/RAC.AU\">Race Oncology</a> (ASX:RAC) filed a new composition of matter patent application as well as two additional patent applications covering the optimal manufacturing, formulation, and uses of (E,E)-bisantrene isomer after scientific discoveries into the nature of bisantrene, according to a Tuesday Australian bourse filing.</p><p>The firm discovered that each isomer of bisantrene has differing biological properties and anticancer activity. The bisantrene isomers are generated during chemical synthesis or by exposure to visible light and heat. Only the (E,E)-bisantrene isomer has significant anticancer activity.</p><p>The patent applications were filed on Sept. 12. They requested accelerated examination of the new applications to aid pharmaceutical partnering discussions.</p><p>Its shares jumped 24% in recent trading on Tuesday, reaching the highest point in over two years.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Race Oncology Files Three New Patent Applications After Scientific Discoveries, Shares Jump 24%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRace Oncology Files Three New Patent Applications After Scientific Discoveries, Shares Jump 24%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-09-16 13:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/RAC.AU\">Race Oncology</a> (ASX:RAC) filed a new composition of matter patent application as well as two additional patent applications covering the optimal manufacturing, formulation, and uses of (E,E)-bisantrene isomer after scientific discoveries into the nature of bisantrene, according to a Tuesday Australian bourse filing.</p><p>The firm discovered that each isomer of bisantrene has differing biological properties and anticancer activity. The bisantrene isomers are generated during chemical synthesis or by exposure to visible light and heat. Only the (E,E)-bisantrene isomer has significant anticancer activity.</p><p>The patent applications were filed on Sept. 12. They requested accelerated examination of the new applications to aid pharmaceutical partnering discussions.</p><p>Its shares jumped 24% in recent trading on Tuesday, reaching the highest point in over two years.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RAC.AU","symbol_name":"RACE ONCOLOGY LTD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2567217502","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2567217502","pubTimestamp":1758000658,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Race Oncology  filed a new composition of matter patent application as well as two additional patent applications covering the optimal manufacturing, formulation, and uses of (E,E)-bisantrene isomer after scientific discoveries into the nature of bisantrene, according to a Tuesday Australian bourse filing.The firm discovered that each isomer of bisantrene has differing biological properties and anticancer activity. The bisantrene isomers are generated during chemical synthesis or by exposure to visible light and heat. Only the (E,E)-bisantrene isomer has significant anticancer activity.The patent applications were filed on Sept. 12. They requested accelerated examination of the new applications to aid pharmaceutical partnering discussions.Its shares jumped 24% in recent trading on Tuesday, reaching the highest point in over two years.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RAC.AU":"RACE ONCOLOGY LTD","BK7067":"生物科技","BK7508":"医药生物股"},"translate_title":"Race Oncology在科学发现后提交三项新专利申请，股价大涨24%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RAC.AU":1},"content_text":"Race Oncology (ASX:RAC) filed a new composition of matter patent application as well as two additional patent applications covering the optimal manufacturing, formulation, and uses of (E,E)-bisantrene isomer after scientific discoveries into the nature of bisantrene, according to a Tuesday Australian bourse filing.The firm discovered that each isomer of bisantrene has differing biological properties and anticancer activity. The bisantrene isomers are generated during chemical synthesis or by exposure to visible light and heat. Only the (E,E)-bisantrene isomer has significant anticancer activity.The patent applications were filed on Sept. 12. They requested accelerated examination of the new applications to aid pharmaceutical partnering discussions.Its shares jumped 24% in recent trading on Tuesday, reaching the highest point in over two years.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}